Do inflammatory pathways drive melanomagenesis?

Experimental Dermatology

Volumn 24, Issue 2, 2015, Pages 86-90

  Schneider, Samantha L ^a,b   Ross, Andrew L ^a   Grichnik, James M ^a,c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

Melanoma; Stem cell; Tumor stem cell

Indexed keywords

ADENOSINE TRIPHOSPHATE; CRYOPYRIN; CYCLOOXYGENASE 2; INFLAMMASOME; INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; NONSTEROID ANTIINFLAMMATORY AGENT; PANNEXIN 1; PROSTAGLANDIN E2; PROTEIN; PURINERGIC P2X7 RECEPTOR; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; CARRIER PROTEIN; GAP JUNCTION PROTEIN; NERVE PROTEIN; NLRP3 PROTEIN, HUMAN; PANX1 PROTEIN, HUMAN;

ADAPTIVE IMMUNITY; ANGIOGENESIS; ARTICLE; CANCER GROWTH; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; INFLAMMATION; MACROPHAGE; MELANOMA; MELANOMA CELL; MELANOMAGENESIS; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; CYTOLOGY; EXPERIMENTAL MELANOMA; METABOLISM; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; SKIN TUMOR; STEM CELL;

ADENOSINE TRIPHOSPHATE; ANIMALS; CARCINOGENESIS; CARRIER PROTEINS; CASPASE 1; CONNEXINS; CYCLOOXYGENASE 2; DINOPROSTONE; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; MELANOMA; MELANOMA, EXPERIMENTAL; MICE; NEOPLASTIC STEM CELLS; NERVE TISSUE PROTEINS; RECEPTORS, PURINERGIC P2X7; SKIN NEOPLASMS; STEM CELLS;

EID: 84928360985     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12502     Document Type: Article

References (127)

1. Nevala W K, Vachon C M, Leontovich A A et al. Clin Cancer Res 2009: 15: 1931-1939.
2. Raman D, Baugher P J, Thu Y M et al. Cancer Lett 2007: 256: 137-165.
3. Paramanathan A, Saxena A, Morris D L. Surg Oncol 2014: 23: 31-39.
4. Carlson L M, Kogner P. Oncoimmunology 2013: 2: e24658.
5. Bald T, Quast T, Landsberg J et al. Nature 2014: 507: 109-113.
6. Coffelt S B, de Visser K E. Nature 2014: 507: 48-49.
7. Dunn J H, Ellis L Z, Fujita M. Cancer Lett 2012: 314: 24-33.
8. Thompson B A, Storm M P, Hewinson J et al. Cell Signal 2012: 24: 770-778.
9. Yuahasi K K, Demasi M A, Tamajusuku A S et al. Int J Dev Neurosci 2012: 30: 91-97.
10. Glaser T, de Oliveira S L, Cheffer A et al. PLoS ONE 2014: 9: e96281.
11. Colmont C S, Harding K G, Piguet V et al. Exp Dermatol 2012: 21: 576-580.
12. Ferrari D, Pizzirani C, Adinolfi E et al. J Immunol 2006: 176: 3877-3883.
13. Larsson K P, Hansen A J, Dissing S. J Neurochem 2002: 83: 285-298.
14. Greig A V, Linge C, Healy V et al. J Invest Dermatol 2003: 121: 315-327.
15. Solini A, Cuccato S, Ferrari D et al. Endocrinology 2008: 149: 389-396.
16. Slater M, Scolyer R A, Gidley-Baird A et al. Melanoma Res 2003: 13: 137-145.
17. White N, Butler P E, Burnstock G. Cell Tissue Res 2005: 321: 411-418.
18. Deli T, Varga N, Adam A et al. Int J Cancer 2007: 121: 55-65.
19. Hattori F, Ohshima Y, Seki S et al. Eur J Pharmacol 2012: 695: 20-26.
20. Kahlenberg J M, Dubyak G R. Am J Physiol Cell Physiol 2004: 286: C1100-C1108.
21. Arulkumaran N, Unwin R J, Tam F W. Expert Opin Investig Drugs 2011: 20: 897-915.
22. Dinarello C A. Annu Rev Immunol 2009: 27: 519-550.
23. Adinolfi E, Amoroso F, Giuliani A L. J Osteoporos 2012: 2012: 637863.
24. Adinolfi E, Callegari M G, Cirillo M et al. J Biol Chem 2009: 284: 10120-10128.
25. Adinolfi E, Callegari M G, Ferrari D et al. Mol Biol Cell 2005: 16: 3260-3272.
26. Adinolfi E, Raffaghello L, Giuliani A L et al. Cancer Res 2012: 72: 2957-2969.
27. Wilhelm K, Ganesan J, Muller T et al. Nat Med 2010: 16: 1434-1438.
28. Pelegrin P, Surprenant A. EMBO J 2006: 25: 5071-5082.
29. Iyer S S, Pulskens W P, Sadler J J et al. Proc Natl Acad Sci U S A 2009: 106: 20388-20393.
30. Gudipaty L, Munetz J, Verhoef P A et al. Am J Physiol Cell Physiol 2003: 285: C286-C299.
31. Glaser T, Cappellari A R, Pillat M M et al. Purinergic Signalling 2012: 8: 523-537.
32. Pan T, Li X, Jankovic J. Int J Cancer 2011: 128: 2251-2260.
33. Poornima V, Madhupriya M, Kootar S et al. J Mol Neurosci 2012: 46: 585-594.
34. Riteau N, Baron L, Villeret B et al. Cell Death Dis 2012: 3: e403.
35. Kankkunen P, Valimaki E, Rintahaka J et al. Hum Immunol 2014: 75: 134-140.
36. Ellis L Z, Liu W, Luo Y et al. Biochem Biophys Res Commun 2011: 414: 551-556.
37. Ahmad I, Muneer K M, Tamimi I A et al. Toxicol Appl Pharmacol 2013: 270: 70-76.
38. Liu W, Luo Y, Dunn J H et al. J Invest Dermatol 2013: 133: 518-527.
39. Okamoto M, Liu W, Luo Y et al. J Biol Chem 2010: 285: 6477-6488.
40. Di Virgilio F. Pharmacol Rev 2013: 65: 872-905.
41. Bauernfeind F, Ablasser A, Bartok E et al. Cell Mol Life Sci 2011: 68: 765-783.
42. Sollberger G, Strittmatter G E, Garstkiewicz M et al. Innate Immun 2014: 20: 115-125.
43. Mouawad R, Antoine E C, Gil-Delgado M et al. Melanoma Res 2002: 12: 343-348.
44. Park H, Byun D, Kim T S et al. Immunol Lett 2001: 79: 215-219.
45. Verma D, Bivik C, Farahani E et al. Pigment Cell Melanoma Res 2012: 25: 506-513.
46. Jin Y, Mailloux C M, Gowan K et al. N Engl J Med 2007: 356: 1216-1225.
47. Teulings H E, Overkamp M, Ceylan E et al. Br J Dermatol 2013: 168: 162-171.
48. Byrne K T, Turk M J. Oncotarget 2011: 2: 684-694.
49. Quaglino P, Marenco F, Osella-Abate S et al. Ann Oncol 2010: 21: 409-414.
50. Tu S, Bhagat G, Cui G et al. Cancer Cell 2008: 14: 408-419.
51. Miki C, Konishi N, Ojima E et al. Dig Dis Sci 2004: 49: 970-976.
52. Krelin Y, Voronov E, Dotan S et al. Cancer Res 2007: 67: 1062-1071.
53. Voronov E, Shouval D S, Krelin Y et al. Proc Natl Acad Sci U S A 2003: 100: 2645-2650.
54. Qin Y, Ekmekcioglu S, Liu P et al. Mol Cancer Res 2011: 9: 1537-1550.
55. Kholmanskikh O, van Baren N, Brasseur F et al. Int J Cancer 2010: 127: 1625-1636.
56. Li H J, Reinhardt F, Herschman H R et al. Cancer Discov 2012: 2: 840-855.
57. Dinarello C A. Blood 1996: 87: 2095-2147.
58. Sweeney F J, Wachtmann T S, Eskra J D et al. Mol Cell Endocrinol 2003: 205: 151-157.
59. Bartosh T J, Ylostalo J H, Bazhanov N et al. Stem Cells 2013: 31: 2443-2456.
60. Alcolea S, Anton R, Camacho M et al. J Lipid Res 2012: 53: 630-642.
61. Wang D, Dubois R N. Cancer 2010: 10: 181-193.
62. de Groot D J, de Vries E G, Groen H J et al. Crit Rev Oncol Hematol 2007: 61: 52-69.
63. Roelofs H M, Te Morsche R H, van Heumen B W et al. BMC Gastroenterol 2014: 14: 1.
64. Menter D G, Schilsky R L, DuBois R N. Clin Cancer Res 2010: 16: 1384-1390.
65. Mehrotra S, Morimiya A, Agarwal B et al. J Pathol 2006: 208: 356-363.
66. Kuzbicki L, Lange D, Straczynska-Niemiec A et al. Melanoma Res 2012: 22: 70-76.
67. Chwirot B W, Kuzbicki L. Melanoma Res 2007: 17: 139-145.
68. Mouradian M, Kikawa K D, Johnson E D et al. Prostaglandins Leukot Essent Fatty Acids 2014: 90: 105-115.
69. Zhang H, Cheng S, Zhang M et al. Int J Oncol 2014: 44: 769-780.
70. Huang R Y, Li S S, Guo H Z et al. J Cancer Res Clin Oncol 2014: 140: 375-386.
71. Huang R Y, Li M Y, Ng C S et al. J Mol Cell Biol 2013: 5: 380-390.
72. Bertagnolli M M, Eagle C J, Zauber A G et al. N Engl J Med 2006: 355: 873-884.
73. Arber N, Eagle C J, Spicak J et al. N Engl J Med 2006: 355: 885-895.
74. Harris R E, Beebe-Donk J, Doss H. Oncol Rep 2005: 13: 559-583.
75. Brasky T M, Potter J D, Kristal A R et al. Cancer Causes Control 2012: 23: 431-444.
76. Jacobs E J, Thun M J, Bain E B et al. J Natl Cancer Inst 2007: 99: 608-615.
77. Schreinemachers D M, Everson R B. Epidemiology 1994: 5: 138-146.
78. Rothwell P M, Fowkes F G, Belch J F et al. Lancet 2011: 377: 31-41.
79. Thun M J, Jacobs E J, Patrono C. Nat Rev Clin Oncol 2012: 9: 259-267.
80. Ramirez C C, Ma F, Federman D G et al. Dermatol Surg 2005: 31: 748-752.
81. Harris R E, Beebe-Donk J, Namboodiri K K. Oncol Rep 2001: 8: 655-657.
82. Curiel-Lewandrowski C, Nijsten T, Gomez M L et al. J Invest Dermatol 2011: 131: 1460-1468.
83. Joosse A, Koomen E R, Casparie M K et al. J Invest Dermatol 2009: 129: 2620-2627.
84. Gamba C A, Swetter S M, Stefanick M L et al. Cancer 2013: 119: 1562-1569.
85. Cook N R, Lee I M, Gaziano J M et al. JAMA 2005: 294: 47-55.
86. Asgari M M, Maruti S S, White E. J Natl Cancer Inst 2008: 100: 967-971.
87. Jeter J M, Bonner J D, Johnson T M et al. J Skin Cancer 2011: 2011: 598571.
88. Jeter J M, Han J, Martinez M E et al. Cancer Causes Control 2012: 23: 1451-1461.
89. Rosell A, Arai K, Lok J et al. J Cereb Blood Flow Metab 2009: 29: 933-943.
90. Amano K, Okigaki M, Adachi Y et al. J Mol Cell Cardiol 2004: 36: 469-480.
91. Li Y, Wang L, Pappan L et al. Mol Cancer 2012: 11: 87.
92. Wang L, Liu Z, Li Y et al. Inflamm Res 2012: 61: 1085-1092.
93. Fan Y Y, Davidson L A, Callaway E S et al. Carcinogenesis 2014: 35: 606-612.
94. Grichnik J M. J Invest Dermatol 2008: 128: 2365-2380.
95. Grichnik J M, Burch J A, Schulteis R D et al. J Invest Dermatol 2006: 126: 142-153.
96. Grichnik J M, Ross A L, Schneider S L et al. Exp Dermatol 2014: 23: 310-313.
97. Zhong Z, Zhai Y, Liang S et al. Nat Commun 2013: 4: 1611.
98. Jabaut J, Ather J L, Taracanova A et al. Free Radical Biol Med 2013: 60: 233-245.
99. Wang C, Ye Z, Zheng J et al. Undersea Hyperb Med 2013: 40: 505-511.
100. Kerr-Valentic M A, Samimi K, Rohlen B H et al. Plast Reconstr Surg 2009: 123: 184-191.
101. Spring P M, Myers J N, El-Naggar A K et al. Ann Otol Rhinol Laryngol 2001: 110: 369-376.
102. Gul U, Kilic A. Ann Plast Surg 2006: 56: 406-408.
103. Ribero S, Grassi M, Caliendo V et al. Ann Plast Surg 2012: 69: 27-29.
104. Atzeni M, Serratore F, Zaccheddu F et al. Melanoma Res 2009: 19: 195-198.
105. Kikuchi H, Nishida T, Kurokawa M et al. J Dermatol 2003: 30: 617-624.
106. Gan B S, Colcleugh R G, Scilley C G et al. J Am Acad Dermatol 1995: 32: 1058-1059.
107. Lee S H, Williams M V, Dubois R N et al. J Biol Chem 2005: 280: 28337-28346.
108. Speed N, Blair I A. Cancer Metastasis Rev 2011: 30: 437-447.
109. Hoek K S, Goding C R. Pigment Cell Melanoma Res 2010: 23: 746-759.
110. Balkwill F, Mantovani A. Lancet 2001: 357: 539-545.
111. Curiel-Lewandrowski C, Swetter S M, Einspahr J G et al. Cancer 2012: 118: 5848-5856.
112. Hiesse C, Rieu P, Kriaa F et al. Transpl Proc 1997: 29: 831-833.
113. Jensen P, Hansen S, Moller B et al. J Am Acad Dermatol 1999: 40: 177-186.
114. Glover M T, Deeks J J, Raftery M J et al. Lancet 1997: 349: 398.
115. Behrend M, Kolditz M, Kliem V et al. Transpl Proc 1997: 29: 834-835.
116. Sanchez E Q, Marubashi S, Jung G et al. Liver Transpl 2002: 8: 285-291.
117. Bouwes Bavinck J N, Hardie D R, Green A et al. Transplantation 1996: 61: 715-721.
118. Hartevelt M M, Bavinck J N, Kootte A M et al. Transplantation 1990: 49: 506-509.
119. Wolchok J D, Kluger H, Callahan M K et al. N Engl J Med 2013: 369: 122-133.
120. Weber J S, Kudchadkar R R, Yu B et al. J Clin Oncol 2013: 31: 4311-4318.
121. Hamid O, Schmidt H, Nissan A et al. J Transl Med 2011: 9: 204.
122. O'Day S J, Maio M, Chiarion-Sileni V et al. Ann Oncol 2010: 21: 1712-1717.
123. Prieto P A, Yang J C, Sherry R M et al. Clin Cancer Res 2012: 18: 2039-2047.
124. Weber J, Thompson J A, Hamid O et al. Clin Cancer Res 2009: 15: 5591-5598.
125. Wolchok J D, Neyns B, Linette G et al. Lancet Oncol 2010: 11: 155-164.
126. Hodi F S, O'Day S J, McDermott D F et al. N Engl J Med 2010: 363: 711-723.
127. Reddi A, Powers M A, Dellavalle R P. Exp Dermatol 2014: 23: 345-346.